Related Experiment Video

Updated: May 31, 2025

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

8.5K

Dynamic Multilevel Regulation of EGFR, KRAS, and MYC Oncogenes: Driving Cancer Cell Proliferation Through

Mario Seres1, Katarina Spacayova1,2, Zdena Sulova1

  • 1Institute of Molecular Physiology and Genetics, Centre of Bioscience, Slovak Academy of Sciences, Dúbravská Cesta 9, 84005 Bratislava, Slovakia.

Cancers
|January 25, 2025
PubMed

Insights

Epidermal Growth Factor Receptor (EGFR) and RAS/MYC oncogenes drive cancer by altering gene expression. Targeting these deregulated pathways through phenotyping offers potential cancer treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Epidermal Growth Factor Receptor (EGFR) signaling is crucial for normal cellular functions.
  • Deregulation of EGFR, RAS, and MYC pathways is a hallmark of tumorigenesis.
  • These pathways control cell proliferation, migration, apoptosis, and metabolic reprogramming.

Purpose of the Study:

  • To review the deregulation of EGFR, RAS, and MYC expression in cancer.
  • To explore the role of epigenetic and post-translational modifications in this deregulation.
  • To discuss the therapeutic potential of targeting these key cancer-related proteins.

Main Methods:

  • Literature review focusing on EGFR, RAS, and MYC signaling pathways.
  • Analysis of genetic, epigenetic, and post-translational modifications.
  • Exploration of therapeutic strategies targeting these oncogenes.

Main Results:

  • EGFR regulates gene expression via nuclear translocation or cytoplasmic tyrosine kinase activity.
  • RAS and MYC oncogenes promote key tumorigenic processes.
  • (Epi)genetic alterations and post-translational modifications contribute to EGFR, RAS, and MYC deregulation.

Conclusions:

  • Targeting deregulated EGFR, RAS, and MYC pathways holds therapeutic promise.
  • Phenotyping neoplastic tissues is essential for guiding cancer treatment decisions.
  • Understanding regulatory mechanisms is key to developing effective cancer therapies.
Keywords:
EGFRKRASMYCepigenetic and non-epigenetic regulation

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

6.7K
Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

190

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.1K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.9K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K